证券代码：688202 证券简称：美迪西 公告编号：2026-003 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ● 经上海美迪西生物医药股份有限公司（以下简称"公司"）财务部门初步测算，预计2025年度将出现亏 损，公司实现归属于母公司所有者的净利润为-18,600万元到-12,400万元，与上年同期（法定披露数 据）相比，亏损预计减少14,485万元到20,685万元，同比减亏43.78%至62.52%。 ● 预计2025年年度实现归属于母公司所有者的扣除非经常性损益后的净利润为-20,400万元到-13,600万 元，与上年同期（法定披露数据）相比，亏损预计减少14,371万元到21,171万元，同比减亏41.33%至 60.89%。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日。 （二）业绩预告情况 （1）经公司财务部门初步测算，预计2025年年度实现归属于母公司所有者的净利润为-18,600万元 到-12,400万元，与上年同期（法定披露数据）相比，亏损 ...

Group 1 - The company expects a negative net profit for the fiscal year 2025, from January 1 to December 31, with the specific amount to be confirmed later [2] - The company has communicated with its accounting firm regarding the earnings forecast, and there are no significant disagreements on this matter [2] Group 2 - The company is focusing on its core business and enhancing resource allocation, leading to revenue growth in key areas such as measurement and surveying, precision agriculture, and overseas markets despite increased market competition [3] - The company plans to make impairment provisions for inventory, goodwill, and receivables totaling between 90 million to 120 million yuan, with the final amount subject to the accountant's approval [3] - The company is undergoing strategic adjustments and restructuring its business, which has resulted in the divestment of non-core businesses and inefficient assets, negatively impacting overall profitability due to revenue decline and increased costs in some business units [3]

Group 1 - The company expects a negative net profit for the fiscal year 2025, covering the period from January 1, 2025, to December 31, 2025 [1] - The preliminary financial data for the performance forecast has not been audited and will be finalized in the annual report [3] Group 2 - The increase in the price of key raw materials, such as cobalt tetroxide and lithium carbonate, has led to adjustments in the sales prices of the company's new energy cathode materials, resulting in a recovery of product gross margins [2] - The company has implemented cost control measures across procurement, R&D, processes, and supply chains, which have improved overall profitability [2] - The company has strengthened accounts receivable management, leading to a partial reversal of previously recognized credit impairment losses [2] Group 3 - A significant shareholder, Mr. Wang Guojiang, will have 5,463,113 shares auctioned, representing 34.49% of his holdings and 1.98% of the company's total shares [6] - If the auctioned shares are successfully transferred, Mr. Wang's total holdings will decrease from 20,301,818 shares to 14,838,705 shares, reducing his ownership percentage from 7.37% to 5.39% [6][7] - The auction will not result in a change of control for the company, as Mr. Wang is not the controlling shareholder [7][8]

证券代码：600969 证券简称：郴电国际 公告编号：2026-007 湖南郴电国际发展股份有限公司 2025年年度业绩预盈公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 业绩预告的具体适用情形：净利润实现扭亏为盈。 ● 湖南郴电国际发展股份有限公司（以下简称"公司"）2025年年度实现归属于母公司所有者的净利润预 计为6,000万元到9,000万元，与上年同期-3,627.35万元相比，将实现扭亏为盈。 ● 预计2025年年度实现归属于母公司所有者的扣除非经常性损益后的净利润3,600万元到5,400万元。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日。 四、风险提示 （三）本次业绩预告数据未经注册会计师审计。 二、上年同期经营业绩和财务状况 （一）利润总额：12,798.43万元。归属于母公司所有者的净利润：-3,627.35万元。归属于母公司所有者 的扣除非经常性损益的净利润：-10,974.07万元。 （二）每股收益：-0.0980元。 （二）业绩预告情 ...

Core Viewpoint - The company, Hubei Wanrun New Energy Technology Co., Ltd., forecasts a significant reduction in losses for the fiscal year 2025 compared to the previous year, driven by improved sales and cost management strategies [3][6]. Group 1: Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -480 million yuan and -400 million yuan, representing a reduction in losses of 390.37 million yuan to 470.37 million yuan, an increase of 44.85% to 54.04% year-on-year [3]. - The forecasted net profit, excluding non-recurring gains and losses, is expected to be between -429 million yuan and -358 million yuan, indicating a reduction in losses of 462.73 million yuan to 533.73 million yuan, with a year-on-year increase of 51.89% to 59.85% [3]. Group 2: Previous Year Performance - In 2024, the company reported a total profit of -991.61 million yuan, with a net profit attributable to shareholders of the parent company at -870.37 million yuan, and a net profit excluding non-recurring gains and losses at -891.73 million yuan [5]. - The earnings per share for 2024 were reported at -7.00 yuan per share [5]. Group 3: Reasons for Performance Changes - The company has actively developed new products and expanded sales markets, resulting in a significant year-on-year increase in the sales volume of lithium iron phosphate, despite a decrease in the average price of lithium carbonate [6]. - Improved inventory management and cost reduction measures are expected to lead to a decrease in the provision for inventory impairment, contributing to a narrower overall loss compared to the previous year [6]. - The company utilizes a pricing model for some lithium carbonate procurement, which has led to recognition of fair value changes as non-recurring gains and losses due to rapid price increases in the fourth quarter [6].

Core Viewpoint - The company, Suzhou Kaiweite Semiconductor Co., Ltd., anticipates a significant loss in net profit for the year 2025, projecting a net loss between 68 million to 96 million yuan compared to the previous year [2][3]. Financial Performance Forecast - The estimated net profit attributable to the parent company is projected to be between -68 million yuan and -96 million yuan for 2025 [2]. - The estimated net profit after deducting non-recurring gains and losses is projected to be between -78 million yuan and -106 million yuan [3]. - The previous year's net profit attributable to the parent company was -97.19 million yuan, with a total profit of -105.13 million yuan [5]. Reasons for Performance Changes - The company is focusing on four core application scenarios: BLDC motor drives, industrial and automotive power supplies, new energy and smart grids, and high-reliability power supplies, which are expected to enhance market competitiveness [7]. - Despite a strategic shift and market expansion, the company still faces losses due to increased competition and the need for asset impairment provisions [7]. - Future strategies include cost reduction and efficiency improvement measures, such as optimizing supply chain management and enhancing product yield [7].

Group 1 - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -480 million and -400 million yuan, representing a reduction in losses of 390.37 million to 470.37 million yuan, an increase of 44.85% to 54.04% compared to the previous year [3] - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -429 million and -358 million yuan, indicating a reduction in losses of 462.73 million to 533.73 million yuan, with a year-on-year increase of 51.89% to 59.85% [3] - The company's performance in 2024 showed a total profit of -991.61 million yuan, with a net profit attributable to shareholders of the parent company at -870.37 million yuan [5] Group 2 - The company has actively developed new products and expanded sales markets, resulting in a significant year-on-year increase in the sales volume of lithium iron phosphate, despite a decrease in the average price of lithium carbonate [6] - The company expects a reduction in the provision for inventory impairment due to improved inventory management and cost reduction measures, leading to a narrowing of overall performance losses compared to the previous year [6] - The company has adopted a pricing model for some lithium carbonate procurement, which has resulted in fair value changes being recognized as non-recurring gains and losses due to rapid price increases in the fourth quarter [6]

Group 1 - The company expects a significant decline in revenue for the year 2025, projecting an operating income between 120 million to 150 million yuan, a decrease of 113.28 million to 143.28 million yuan compared to the previous year, representing a year-on-year decline of 43.03% to 54.42% [3] - The company anticipates a net loss attributable to shareholders of the parent company ranging from -160 million to -120 million yuan, which is a reduction in loss of 196.90 million to 236.90 million yuan compared to the previous year, indicating a year-on-year decrease in loss of 55.17% to 66.38% [3] - The projected net loss attributable to shareholders after excluding non-recurring gains and losses is expected to be between -165 million to -125 million yuan, with a reduction in loss of 193.53 million to 233.53 million yuan compared to the previous year, reflecting a year-on-year decrease in loss of 53.98% to 65.14% [4] Group 2 - The company reported a total profit loss of -388.64 million yuan for the year 2024, with a net loss attributable to shareholders of the parent company at -356.90 million yuan [6] - The earnings per share for the year 2024 were reported at -1.3007 yuan [7] Group 3 - The decline in performance is attributed to intensified market competition due to domestic pharmaceutical industry procurement policies and the introduction of similar competing products, along with a decrease in flu cases in the first three quarters of 2025, leading to reduced operating income and gross margin [8] - The company has maintained a high level of R&D investment to sustain its core competitiveness while implementing cost control measures, resulting in a significant decrease in sales and management expenses compared to the previous year [8] - Future strategies include adjusting marketing strategies, accelerating R&D progress, launching new products, optimizing product sales structure, and enhancing cost management to achieve sustainable and high-quality development [8]

证券代码：688693 证券简称：锴威特 公告编号：2026-001 苏州锴威特半导体股份有限公司 2025年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）利润总额：-10,512.62万元。归属于母公司所有者的净利润：-9,718.93万元。归属于母公司所有 者的扣除非经常性损益的净利润：-10,825.84万元。 （二）每股收益：-1.32元。 三、本期业绩变化的主要原因 报告期内，公司把握市场变化趋势，结合自身的优劣势分析，确立"以应用牵引产品技术迭代"的发展路 径，聚焦BLDC电机驱动、工业及车用电源、新能源与智能电网、高可靠电源及电机驱动四大核心应用 场景，全面重构产品体系，打造面向客户的整套芯片解决方案，有效帮助客户在提升产品性能的同时降 低系统成本，显著增强公司市场竞争力。得益于上述战略布局的快速落地与市场拓展的积极推进，2025 年营业收入较上年同期保持增长恢复态势，公司经营规模实现稳步提升。 （一）业绩预告期间 2025年1月1日至2025年12月31日。 （二 ...

Core Viewpoint - The company, Hengdian Film Co., Ltd., forecasts a turnaround in its financial performance for the year 2025, expecting a net profit of between 130 million to 180 million yuan, compared to a loss in the previous year [2][4]. Financial Performance Forecast - The company anticipates a net profit attributable to shareholders of 130 million to 180 million yuan for the year 2025 [2][4]. - The expected net profit after deducting non-recurring gains and losses is projected to be between 62 million to 90 million yuan [2][4]. - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. Previous Year’s Financial Performance - In the previous year, the total profit was -85.21 million yuan, with a net loss attributable to shareholders of -96.38 million yuan [6]. - The net profit after deducting non-recurring gains and losses was -223.34 million yuan [6]. - The earnings per share for the previous year were -0.15 yuan [7]. Reasons for Profit Turnaround - The film screening and related derivative business saw revenue growth due to a recovery in the industry, with the Chinese film market's total box office reaching 51.83 billion yuan, a year-on-year increase of 21.95% [8]. - The number of moviegoers in urban cinemas reached 1.238 billion, up 22.57% year-on-year [8]. - The company has strengthened its management and diversified its operations, contributing to improved overall operational efficiency [8]. - Several films produced by the company's subsidiary, including "Boonie Bears: Rebooting the Future" and "The Legend of the Condor Heroes: The Hero of the Great", are set to be released, along with a focus on developing short drama content [8][9].